SEC Comment Letter for Lineage Cell Therapeutics, Inc. (LCTX) (CIK 0000876343) (LCTX) — Apr 3, 2013
Lineage Cell Therapeutics, Inc. (LCTX) (CIK 0000876343)
Date: April 3, 2013 · CIK: 0000876343 · Accession: 0000000000-13-017752
AI Filing Summary & Sentiment
Reasoning
Letter
April 3, 2013 Via E -mail Michael D. West Chief Executive Officer BioTime, Inc. 1301 Harbor Bay Parkway, Suite 100 Alameda, CA 94502
Re: BioTime, Inc. Preliminary Proxy Statement on Schedule 14A Filed March 5, 2013 File No. 001 -12830
Dear Mr. West :
We have completed our review of your filing. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are res ponsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.
Sincerely,
/s/ Daniel Greenspan for
Show Raw Text
April 3, 2013 Via E -mail Michael D. West Chief Executive Officer BioTime, Inc. 1301 Harbor Bay Parkway, Suite 100 Alameda, CA 94502 Re: BioTime, Inc. Preliminary Proxy Statement on Schedule 14A Filed March 5, 2013 File No. 001 -12830 Dear Mr. West : We have completed our review of your filing. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are res ponsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/ Daniel Greenspan for Jeffrey P. Riedler Assistant Director cc: Via E -mail Diane Frankle Kaye Scholer LLP